Concepedia
Statistics
Publications
27
Citations
2.6K
H-Index
23
Active since
1976
Affiliations
Eli Lilly (United States)(Current)
Daiichi Sankyo (United States)
Eli Lilly (United Kingdom)
Eli Lilly (Singapore)
Profil Institute for Metabolic Research
C. Steven Ernest is an author at Eli Lilly (United States) specializing in pharmacology, pharmacokinetics, and medicine.
Publications per year
1976–2024
Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
John T. Brandt, Sandra Close, Stephen J. Iturria et al. · Journal of Thrombosis and Haemostasis · 2007 · 730 citations
Medicine, Pharmacokinetics, Pharmacology +14
Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics Differently
Nazar Farid, Christopher D. Payne, D. S. Small et al. · Clinical Pharmacology & Therapeutics · 2007 · 322 citations
Medicine, Pharmacokinetics, Pharmacology +17
Mechanism-Based Inactivation of CYP3A by HIV Protease Inhibitors
C. Steven Ernest, Stephen D. Hall, David Jones · Journal of Pharmacology and Experimental Therapeutics · 2005 · 251 citations
Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel
Christopher D. Payne, Ying Grace Li, David S. Small et al. · Journal of Cardiovascular Pharmacology · 2007 · 167 citations
Effect of Potent CYP2D6 Inhibition by Paroxetine on Atomoxetine Pharmacokinetics
Donna J. Belle, C. Steven Ernest, John‐Michael Sauer et al. · The Journal of Clinical Pharmacology · 2002 · 94 citations · Full text
1–5 of 27